Similarly, after the application of camrelizumab, elevated expression of IFN‐γ and GzmB within CD8+ T cells was observed in the tumours with VISTAlow TAMs rather than VISTAhigh TAMs (Figure 7C,D). The gene discussed is CD8A; the disease is neoplasm.